Anifrolumab Shows Promising 6-Month Outcomes in SLE: Lancet Written By Dr. Shravani Dali23 March 2026 9:30 PM ISTIn a real-world, multicenter cohort study published in The Lancet Rheumatology, anifrolumab demonstrated positive results in patients with systemic...
Ritlecitinib Effective and Well-Tolerated for Severe Alopecia Areata, suggests study Written By Dr Riya Dave22 March 2026 8:30 PM ISTResearchers have found in a multicentre real-world study that ritlecitinib 50 mg/day was found to be an effective and well-tolerated treatment for...
Linezolid Comparable to Clindamycin in Severe or Necrotizing SSTIs, Suggests Study Written By Medha Baranwal20 March 2026 8:45 PM ISTUSA: Researchers have found in a new study that linezolid and clindamycin show similar effectiveness in treating severe or necrotizing skin and soft...
Icotrokinra Shows Strong Efficacy and Safety in Plaque Psoriasis: Meta-Analysis Written By Medha Baranwal19 March 2026 8:30 PM ISTLibya: New research, published in the International Journal of Dermatology, has demonstrated high efficacy and good tolerability of oral icotrokinra...
Hidradenitis Suppurativa Linked to Higher Risk of Self-Harm and Suicide: JAMA Written By Medha Baranwal18 March 2026 8:45 PM ISTDenmark: A large Danish registry-based study has found that patients with hidradenitis suppurativa had about twice the rate of self-harm, including...
Semaglutide Improves Clinical and Metabolic Outcomes in Hidradenitis Suppurativa with Obesity: Study Written By Medha Baranwal18 March 2026 10:00 AM ISTSpain: A new study has found that treatment with Semaglutide in patients with Hidradenitis Suppurativa and obesity led to improvements in weight, body...
FDA Approves Deucravacitinib for Active Psoriatic Arthritis Written By Dr. Kamal Kant Kohli16 March 2026 8:15 PM ISTThe U.S. Food and Drug Administration has approved Deucravacitinib (Sotyktu) for the treatment of adults with Psoriatic Arthritis. This oral drug is a...
Nemolizumab Demonstrates Sustained Long-Term Benefit in Prurigo Nodularis: Study Written By Dr. Kamal Kant Kohli15 March 2026 9:30 PM ISTLong-term results from the OLYMPIA open-label extension study show that nemolizumab (Nemluvio) provides durable efficacy and good tolerability for up...
Dupilumab restores skin barrier function in children with moderate-to-severe atopic dermatitis, study shows Written By Dr. Kamal Kant Kohli13 March 2026 10:15 PM ISTA new study led by investigators at National Jewish Health and published in Annals of Allergy, Asthma & Immunology, shows that treatment with...
Once-Daily Roflumilast Cream Delivers Lasting Benefits in Atopic Dermatitis: Study Shows Written By Medha Baranwal12 March 2026 8:30 PM ISTUSA: A subgroup analysis published in The Journal of Allergy and Clinical Immunology reports that roflumilast cream may provide sustained improvement...
Adjunctive Low-Level Laser Therapy fails to reduce Postoperative Pain in irreversible pulpitis: Study Written By Dr. Shravani Dali12 March 2026 8:30 PM ISTResearchers have found in a pragmatic emergency-care study that adjunctive low-level laser therapy did not demonstrate a reduction in postoperative...
Hyaluronic Acid Fillers: A Promising Option for systemic sclerosis and Morphea: Study Written By Jacinthlyn Sylvia11 March 2026 8:45 PM ISTA new study published in the journal of Autoimmunity Reviews that Hyaluronic acid (HA) fillers seem to be a safe, minimally invasive treatment for...
